Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Clearside Biomedical Inc (NASDAQ: CLSD) closed at $1.07 in the last session, up 5.94% from day before closing price of $1.01. In other words, the price has increased by $5.94 from its previous closing price. On the day, 0.11 million shares were traded. CLSD stock price reached its highest trading level at $1.07 during the session, while it also had its lowest trading level at $1.01.
Ratios:
We take a closer look at CLSD’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.49 and its Current Ratio is at 4.49.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on August 21, 2024, initiated with a Buy rating and assigned the stock a target price of $6.
On June 25, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $5.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 01 ’24 when Chong Ngai Hang Victor bought 36,500 shares for $1.00 per share. The transaction valued at 36,500 led to the insider holds 100,000 shares of the business.
Chong Ngai Hang Victor bought 23,500 shares of CLSD for $24,910 on Jun 24 ’24. The Chief Medical Officer now owns 63,500 shares after completing the transaction at $1.06 per share. On May 15 ’24, another insider, YERXA BENJAMIN R, who serves as the Director of the company, bought 7,813 shares for $1.31 each. As a result, the insider paid 10,235 and bolstered with 17,957 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLSD now has a Market Capitalization of 81152552 and an Enterprise Value of 107534552. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.54. Its current Enterprise Value per Revenue stands at 13.96 whereas that against EBITDA is -4.393.
Stock Price History:
The Beta on a monthly basis for CLSD is 2.10, which has changed by -0.17054266 over the last 52 weeks, in comparison to a change of 0.22894537 over the same period for the S&P500. Over the past 52 weeks, CLSD has reached a high of $2.12, while it has fallen to a 52-week low of $0.80. The 50-Day Moving Average of the stock is 9.17%, while the 200-Day Moving Average is calculated to be -5.18%.
Shares Statistics:
According to the various share statistics, CLSD traded on average about 249.79K shares per day over the past 3-months and 249240 shares per day over the past 10 days. A total of 74.75M shares are outstanding, with a floating share count of 64.33M. Insiders hold about 15.29% of the company’s shares, while institutions hold 15.22% stake in the company. Shares short for CLSD as of 1738281600 were 777769 with a Short Ratio of 3.11, compared to 1735603200 on 741677. Therefore, it implies a Short% of Shares Outstanding of 777769 and a Short% of Float of 1.09.
